-
HPA039425-100UL
Anti-LRRC43 antibody produced in rabbit (C15-1455-729)
Price: $928.29List Price: $1,031.43Immunogen leucine rich repeat containing 43 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization -
HPA047606-100UL
Anti-LRRC43 antibody produced in rabbit (C15-1459-283)
Price: $928.29List Price: $1,031.43Immunogen leucine rich repeat containing 43 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are -
HPA023372-100UL
Anti-LRRC45 antibody produced in rabbit (C15-1450-373)
Price: $879.43List Price: $977.14The gene LRRC45 (leucine rich repeat containing 45) encodes a 72kDa protein that contains several N-terminal leucine-rich repeat (LRR) domains and a long coiled-coil domain at the C terminus. It is localized at the proximal ends of the mother and -
HPA023382-100UL
Anti-LRRC45 antibody produced in rabbit (C15-1450-378)
Price: $879.43List Price: $977.14The gene LRRC45 (leucine rich repeat containing 45) encodes a 72kDa protein that contains several N-terminal leucine-rich repeat (LRR) domains and a long coiled-coil domain at the C terminus. It is localized at the proximal ends of the mother and -
HPA024768-100UL
Anti-LRRC45 antibody produced in rabbit (C15-1450-881)
Price: $879.43List Price: $977.14The gene LRRC45 (leucine rich repeat containing 45) encodes a 72kDa protein that contains several N-terminal leucine-rich repeat (LRR) domains and a long coiled-coil domain at the C terminus. It is localized at the proximal ends of the mother and -
HPA021882-100UL
Anti-LRRC46 antibody produced in rabbit
Price: $879.43List Price: $977.14LRRC46 (leucine rich repeat containing 46) is classified as a differentially expressed gene-probes (DEGs). Its higher expressions have been observed in estrogen receptor positive breast cancer tumors. -
HPA008512-100UL
Anti-LRRC47 antibody produced in rabbit (C15-1447-158)
Price: $879.43List Price: $977.14Immunogen Leucine-rich repeat-containing protein 47 recombinant protein epitope signature tag (PrEST) Sequence PGNALKRFLTSQTKLHEDLCEKRTAATLATHELRAVKGPLLYCARPPQDLKIVPLGRKEAKAKELVRQLQLEAEEQRKQKKRQSVSGLHRYLHLLDGNENYPCLVDADGDVISFPPITNSEK Application -
HPA012018-100UL
Anti-LRRC47 antibody produced in rabbit (C15-1447-710)
Price: $879.43List Price: $977.14Immunogen Leucine-rich repeat-containing protein 47 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a -
HPA015596-100UL
Anti-LRRC49 antibody produced in rabbit
Price: $879.43List Price: $977.14Immunogen leucine rich repeat containing 49 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are -
HPA058986-100UL
Anti-LRRC4B antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen leucine rich repeat containing 4B Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization -
HPA054800-100UL
Anti-LRRC4C antibody produced in rabbit (C15-1461-793)
Price: $928.29List Price: $1,031.43Immunogen leucine rich repeat containing 4C Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization -
HPA075816-100UL
ANTI-LRRC4C ANTIBODY PRODUCED IN RABBIT (C15-1466-779)
Price: $977.14List Price: $1,085.71Immunogen leucine rich repeat containing 4C Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization